Month: June 2024

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) — Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the “Board”) adopted the Sharecare, Inc. 2024 Inducement Plan (the “Inducement Plan”), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company (or following a bona fide period of non-employment) as an inducement material to such individuals entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Company allocated up to 5,000,000 shares of common...

NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT. Amsterdam, 19 June 2024 – Azerion Group N.V. (the “Company” or “Azerion“) announces today that it has, following a bookbuilding process, successfully placed a subsequent bond issue (the “Subsequent Bond Issue” or the “Subsequent Bonds”) in an amount of EUR 50 million under the Company’s existing senior secured floating rate bond framework of EUR 300 million with ISIN NO0013017657 (the “Bonds”). Following the Subsequent Bond Issue, the outstanding aggregate principal amount under the Bonds will be EUR 215 million....

Contemporary 700-sq. ft. Material Lounge features comprehensive portfolio of interior materials, fabrics and components for aircraft enhancement Customers can select colour, texture and style options to create unique interior spaces Bombardier’s London Biggin Hill Service Centre is the largest business aviation maintenance, repair and overhaul (MRO) facility in the UK for business aircraft offering customers a wide range of service optionsMONTREAL, June 19, 2024 (GLOBE NEWSWIRE) — Bombardier and F/LIST have announced the opening of a contemporary, 700-sq. ft. Material Lounge at Bombardier’s London Biggin Hill Service Centre located at the London Biggin Hill Airport. The new Material Lounge is the largest, most comprehensive portfolio of interior materials, fabrics and components that Bombardier has housed at one of its international...

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) — Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), announced today that Cboe Canada has approved the Company’s renewed normal course issuer bid (“NCIB”) to purchase, for cancellation, up to 7,571,314 of Base Carbon’s common shares (“Common Shares”). The Company’s current normal course issuer bid will end on June 20, 2024, and pursuant to the renewed NCIB, Base Carbon may purchase over a period of 12 months starting June 21, 2024, and ending June 20, 2025, up to 7,571,314 Common Shares representing approximately 6.5% of the 115,995,334 issued and outstanding Common Shares and 10% of the Company’s public float as of June 17, 2024. On any given...

Patent No. US 11,998,632 B2 (“Patent”) covers Avicanna’s self-emulsifying drug delivery system (“SEDDS”) oral cannabinoid composition and methods of treating neuropathic pain TORONTO, June 19, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce the United States Patent and Trademark Office (“USPTO”) issuance of the Patent covering Avicanna’s SEDDS oral cannabinoid compositions and methods for treating neuropathic pain. “We are delighted to announce the USPTO’s issuance of the Patent covering our SEDDS drug delivery technology. Research, development, and evaluation of the potential role of cannabinoids in advanced drug delivery...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 19 JUNE 2024 AT 15.00 P.M. EET, INSIDE INFORMATIONInside information: Oma Savings Bank Plc’s CEO Pasi Sydänlammi leaves his position immediately       The Board of Directors of Oma Savings Bank Plc (OmaSp or the Company) and the CEO Pasi Sydänlammi have agreed that Sydänlammi will leave his position as the CEO immediately. Sydänlammi has been the CEO of OmaSp since 2009. The Board of Directors will immediately commence the search process to select a new CEO. The deputy CEO Sarianna Liiri has been appointed as an interim CEO of OmaSp. She has been a member of OmaSp’s Management team since 2015 and the CFO since 2018 with responsibility for Finance, Treasury and HR. She has previously served as the Chief Administrative Officer between 2015 and 2018 and the Development Manager between...

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators conclude that clinical outcomes of RELIEF-DPN 1 support commencement of Lexicon’s dose-ranging Phase 2b PROGRESS trial, currently enrolling patients THE WOODLANDS, Texas, June 19, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Diabetes Care, the peer-reviewed journal of the American Diabetes Association, has published a research paper on the company’s Phase 2 RELIEF-DPN-1 clinical trial investigating LX9211 for the treatment of diabetic peripheral neuropathic pain (DPNP). In the proof-of-concept RELIEF-DPN-1 study, the effects of LX9211 were assessed over an 11-week evaluation period, which...

Vancouver, BC, Canada, June 19, 2024 (GLOBE NEWSWIRE) — RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2), (Munich: A2PU92) is thrilled to announce a strategic negotiations with a U.K. based financial group for the sale of its Spanish based subsidiary Revolupay EP, S.L.U. RevoluGROUP Canada Inc. reported today that it is in negotiations with a U.K. based financial group for the sale of its Spanish based subsidiary Revolupay EP, S.L.U, a licensee of payment institution through the Central Bank of Spain.  The principal terms of the proposed sale are as follows:  the purchase price is approximately 4.3 million dollars Canadian (subject to final negotiation, adjustments and currency fluctuations); the parties finalize a Share Purchase Agreement; the transfer of the shares must be authorized by the Central Bank in Spain;...